International Journal of Nursing Studies
Volume 36, Issue 3 , Pages 223-233 , June 1999

Effects of cognitive-behavioral interventions on quality of life in persons with HIV

Received 25 June 1998 ,Revised 29 October 1998 ,Accepted 11 February 1999.

References 

  1. Antoni MH, Baggett L, August S, Klimas N, Schneiderman N, Fletcher MA. Cognitive-Behavioral stress management intervention buffers distress responses and immunologic changes following notification of HIV-1 seropositivity. Journal of Clinical and Consulting Psychology. 1991;59(6):906–915
  2. Auerbach JE, Olesson TD, Solomon GF. A behavioral medicine intervention as an adjunctive treatment for HIV-related illness. Psychology and Health. 1992;6:325–334
  3. Barker S, Tindall B, Carballo M. Quality of life and clinical trials in HIV infection. Lancet. 1990;335(8696):1045
  4. Benson H. The Relaxation Response. New York: Avon; 1975;
  5. Bergner M, Bobbit RA, Carter WB, Gilson BS. The sickness impact profile: Development and final revision of a health status measure. Medical Care. 1981;19:787–805
  6. Black PH. Central nervous system-immune system interactions: Psychoneuroendocrinology of stress and its immune consequences. Antimicrobial Agents and Chemotherapy. 1994;38:1–6
  7. Blalock JE. A molecular basis for bidirectional communication between the immune and neuroendocrine systems. Physiological Review. 1989;69:1–32
  8. Bornstein M, Cohen J. Statistical Power Analysis: A Computer Program. Hillsdale, NJ: Lawrence Earlbaum Associates; 1988;
  9. Centers for Disease Control and Prevention, 1998. http://www.cdc.gov./nchstp/hiv_aids/stats/internat.htm/
  10. Centers for Disease Control. Human immunodeficiency virus (HIV) infection codes and new codes for Kaposi's sarcoma. Mortality and Morbidity Weekly Report. 1991;40(RR-9):1–9
  11. Cleary PD, Fowler FJ, Weissman J, Massagli MP, Wilson I, Seage GR, et al. Health-related quality of life in persons with acquired immune deficiency syndrome. Medical Care. 1993;31(7):569–580
  12. Clement M, Hollander H. Natural history and management of the seropositive patient. In:  Sande MA,  Volberding PA editor. The Medical Management of AIDS. Philadelphia: Saunders; 1992;p. 87–96
  13. Collier A, Coombs R, Schoenfeld D, Bassett R, Timpone J, Baruch A, et al. Treatment of human immuunodeficiency virus infection with saquinavir, zidovudine and zalcitabine. New England Journal of Medicine. 1996;334:1011–1017
  14. Dykeman MC, Wallace R, Ferrell P, Jasek J, Tortorice PV. Drug interactions: How they affect people living with HIV/AIDS. JANAC. 1996;7(4):67–79
  15. Eller LS. Effects of two cognitive-behavioral interventions on immunity and symptoms in persons with HIV. Annals of Behavioral Medicine. 1995;17(4):339–347
  16. Esterling BA, Antoni MH, Schneiderman N, Carver CS, LaPierre A, Ironson G, et al. Psychosocial modulation of antibody to Epstein–Barr viral capsid antigen and human herpesvirus Type-6 in in HIV-1 infected and at-risk gay men. Psychosomatic Medicine. 1992;54:354–371
  17. Fawzy FI, Cousins N, Fawzy NW, Kemeny ME, Elashoff R, Morton D. A structured psychiatric intervention for cancer patients: Changes over time in methods of coping and affective disturbance. Archives of General Psychiatry. 1990;47:720–725
  18. Fawzy FI, Kemeny ME, Fawzy NW, Elashoff R, Morton D, Cousins N, et al. A structured psychiatric intervention for cancer patients: Changes over time in immunological measures. Archives of General Psychiatry. 1990;47:729–735
  19. Ferrell BR. The quality of lives: 1,525 voices of cancer. Oncology Nursing Forum. 1996;23(6):907–916
  20. Folkman S, Chesney M, Pollack L, Coates T. Stress, control, coping and depressive mood in human immunodeficiency virus-positive and negative gay men in San Francisco. Journal of Nervous and Mental Disease. 1993;181:409–416
  21. Frank-Stromborg M. Single instruments for measuring quality of life. In:  Frank-Stromborg M editors. Instruments for Clinical Nursing Research. Norwalk, CN: Appleton and Lange; 1988;p. 79–95
  22. Ganz PA, Schag AC, Kahn B, Petersen L, Hirji K. Describing the health-related quality of life impact of HIV infection: findings form a study using the HIV Overview of Problems Evaluation System (HOPES). Quality of Life Research. 1993;2:109–119
  23. Holzemer WL, Wilson HS. Quality of life and the spectrum of HIV infection. Annual Review of Nursing Research. 1995;13:3–29
  24. Kaplan RM, Anderson JP, Wu AW, Mathews WC, Kozin F, Orenstein D. The Quality of Well-being Scale. Applications in AIDS, cystic fibrosis, and arthritis. Medical Care. 1989;27(3 Suppl):S27–43
  25. Keithley JK, Zeller JM, Szeluga DJ, Urbanski PA. Nutritional alterations in persons with HIV infection. Image. 1992;24(3):183–189
  26. Kelly JA, Murphy DA, Bahr GR, Kalichman SC, Morgan MG, Stevenson Y, et al. Outcome of cognitive-based behavioral and support group brief therapies for depressed HIV-infected persons. American Journal of Psychiatry. 1993;150(11):1679–1686
  27. Lovejoy NC, Paul S, Freeman E, Chritianson B. Potential correlates of self-care and symptom distress in homosexual/bisexual men who are HIV positive. Oncology Nursing Forum. 1991;18(7):1175–1185
  28. Lubeck DP, Fries JF. Changes in quality of life among persons with HIV infection. Quality of Life Research. 1992;1:359–366
  29. McCain NL, Zeller JM, Cella DF, Urbanski PA, Novak RM. The influence of stress management training in HIV disease. Nursing Research. 1996;45(4):246–253
  30. Morley JE, Benton D, Solomon GF. The role of stress and opiods as regulators of the immune response. In:  McCubbin JA,  Kaufmann PG,  Nemeroff CB editor. Stress, Neuropeptides and Systemic Disease. San Diego: Academic Press, Inc; 1991;p. 221–231
  31. Mulder N, Antoni MH, Emmelkamp P, Veugelers PJ, Sandfort TG, van de Vijver FA, et al. Psychosocial group intervention and the rate of decline of immunologic parameters in symptomatic HIV infected homosexual men. Psychotherapy and Psychosomatics. 1995;63:185–192
  32. Munck A, Guyre PM. Glucocorticoids and immune function. In:  Ader R,  Felten DL,  Cohen N editor. Psychoneuroimmunology. 2nd ed.. New York: Academic Press; 1991;p. 447–475
  33. National Center for Nursing Research. HIV infection: Prevention and care. Bethesda, MD: U.S. Department of Health and Human Services; 1990;
  34. Nokes KM, Wheeler K, Kendrew J. Development of an HIV assessment tool. Imager. 1994;26(2):133–138
  35. Nunes JA, Raymond SJ, Nicholas PK, Leuner JD, Webster A. Social support, quality of life, immune function and health in persons living with HIV. Journal of Holistic Nursing. 1995;13(2):174–198
  36. Perry S, Fishman B, Jacobsberg L, Frances A. Relationships over 1 year between lymphocyte subsets and psychosocial variables among healthy adults with infection by human immunodeficiency virus. Archives of General Psychiatry. 1992;49:396–401
  37. Rabin BS, Cohen S, Ganguli R, Lysle DT, Cunnick JE. Bidirectional interaction between the central nervous system and the immune system. CRC Critical Reviews in Immunology. 1989;9:279–312
  38. Ragsdale D, Morrow JR. Quality of life as a function of HIV classification. Nursing Research. 1990;39(6):355–359
  39. Sikkema KJ, Kelly JA. Behavioral medicine interventions can improve the quality of life and health of persons with HIV disease. Annals of Behavioral Medicine. 1996;18(1):40–48
  40. Smith JC. Cognitive-Behavioral Relaxation Training. New York: Springer; 1990;
  41. Taylor DN. Effects of a behavioral stress-management program on anxiety, mood, self-esteem and T-cell count in HIV-positive men. Psychological Reports. 1995;76:451–457
  42. Teshima H, Sogawa H, Mizobe K. Application of psychoimmunotherapy in patients with alopecia universalis. Psychotherapy and Psychosomatics. 1991;56:235–241
  43. Van Servellen G, Padilla G, Brecht ML, Knoll L. The relationship of stressful life events, health status and stress-resistance resources in persons with AIDS. Journal of the Association of Nurses in AIDS Care. 1993;4(1):11–22
  44. Wachtel T, Piette J, Mor V, Stein M, Fleishman J, Carpenter C. Quality of life in persons with human immunodeficiency virus infection: Measurement by the Medical Outcomes Study instrument. Annals of Internal Medicine. 1992;116:129–137
  45. Wu AW, Mathews WC, Brysk LT, Atkinson JH, Grant I, Abramson I, et al. Quality of life in a placebo-controlled trial of zidovudine in patients with AIDS and AIDS-related complex. Journal of Acquired Immune Deficiency Syndrome. 1990;3(7):683–690
  46. Wu AW, Rubin HR, Mathews WC, Brysk LM, Bozzette SA, Hardy WD, et al. Functional status and well-being in a placebo-controlled trial of zidovudine in early symptomatic HIV infection. Journal of Acquired Immune Deficiency Syndrome. 1993;6(5):452–458
  47. Wu AW, Rubin HR, Mathews WC, Ware JE, Brysk LT, Hardy WD, et al. A health status questionnaire using 30 items from the medical outcomes study. Medical Care. 1991;29(8):786–798

PII: S0020-7489(99)00018-8

International Journal of Nursing Studies
Volume 36, Issue 3 , Pages 223-233 , June 1999

Article Tools

* Image Usage & Resolution